This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


3vap

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
m (Protected "3vap" [edit=sysop:move=sysop])
Line 3: Line 3:
The entry 3vap is ON HOLD
The entry 3vap is ON HOLD
-
Authors: Voss, M. E., Rainka, M. P., Fleming, M., Peterson, L. H., Belanger, D. B., Siddiqui, M. A., Hruza, A., Voigt, J., Basso, A. D., Gray, K.
+
Authors: Voss, M.E., Rainka, M.P., Fleming, M., Peterson, L.H., Belanger, D.B., Siddiqui, M.A., Hruza, A., Voigt, J., Basso, A.D., Gray, K.
Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity
Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity

Revision as of 05:59, 11 January 2012

Unreleased structure

The entry 3vap is ON HOLD

Authors: Voss, M.E., Rainka, M.P., Fleming, M., Peterson, L.H., Belanger, D.B., Siddiqui, M.A., Hruza, A., Voigt, J., Basso, A.D., Gray, K.

Description: Synthesis and SAR Studies of imidazo-[1,2-a]-pyrazine Aurora kinase inhibitors with improved off target kinase selectivity

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools